Cassava Sciences Inc (NASDAQ: SAVA) on Monday, soared 3.86% from the previous trading day, before settling in for the closing price of $26.91. Within the past 52 weeks, SAVA’s price has moved between $8.79 and $42.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 64.22%. With a float of $41.77 million, this company’s outstanding shares have now reached $42.24 million.
The extent of productivity of a business whose workforce counts for 29 workers is very important to gauge. In terms of profitability, gross margin is 58.82%, operating margin of -5985.86%, and the pretax margin is -752.3%.
Cassava Sciences Inc (SAVA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cassava Sciences Inc is 13.18%, while institutional ownership is 29.66%.
Cassava Sciences Inc (SAVA) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.5 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.4) by -0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 64.22% per share during the next fiscal year.
Cassava Sciences Inc (NASDAQ: SAVA) Trading Performance Indicators
Cassava Sciences Inc (SAVA) is currently performing well based on its current performance indicators. A quick ratio of 3.55 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.37, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach 0.50 in one year’s time.
Technical Analysis of Cassava Sciences Inc (SAVA)
The latest stats from [Cassava Sciences Inc, SAVA] show that its last 5-days average volume of 1.57 million was inferior to 1.7 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 66.30%. Additionally, its Average True Range was 1.97.
During the past 100 days, Cassava Sciences Inc’s (SAVA) raw stochastic average was set at 57.35%, which indicates a significant decrease from 81.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.57% in the past 14 days, which was lower than the 148.80% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.52, while its 200-day Moving Average is $22.88. Now, the first resistance to watch is $28.72. This is followed by the second major resistance level at $29.50. The third major resistance level sits at $30.81. If the price goes on to break the first support level at $26.63, it is likely to go to the next support level at $25.32. Assuming the price breaks the second support level, the third support level stands at $24.54.
Cassava Sciences Inc (NASDAQ: SAVA) Key Stats
Market capitalization of the company is 1.38 billion based on 48,110K outstanding shares. Right now, sales total 0 K and income totals -97,220 K. The company made 0 K in profit during its latest quarter, and -27,940 K in sales during its previous quarter.
